New Era Study: Treatment With Multi Drug Class (MDC) HAART in HIV Infected Patients (NewEra)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00908544
Recruitment Status : Active, not recruiting
First Posted : May 27, 2009
Last Update Posted : November 17, 2017
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
MUC Research GmbH

No Study Results Posted on for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : November 2018
  Estimated Study Completion Date : November 2019